Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Angiogenesis Inhibitors. Found 13 abstracts

Ghatalia P, Zibelman MR, Geynisman DM, Plimack ER. Evolving landscape of the treatment of metastatic clear cell renal cell carcinoma. Clinical advances in hematology & oncology : H&O. 2018 Oct;16(10):677-86.
Ito T, Kutikov A. Kidney cancer in 2014: Key advances promise progress for kidney cancer patients. Nature reviews Urology. 2015 Feb;12(2):69-70.
Ito T, Kutikov A. Kidney cancer in 2014: Key advances promise progress for kidney cancer patients. Nature reviews Urology. 2015 Feb;12(2):69-70.
Lecht S, Chiaverelli RA, Gerstenhaber J, Calvete JJ, Lazarovici P, Casewell NR, Harrison R, Lelkes PI, Marcinkiewicz C. Anti-angiogenic activities of snake venom CRISP isolated from Echis carinatus sochureki. Biochimica et biophysica acta. 2015 Jun;1850(6):1169-79.
Meng MB, Zaorsky NG, Deng L, Wang HH, Chao J, Zhao LJ, Yuan ZY, Ping W. Pericytes: a double-edged sword in cancer therapy. Future Oncol. 2015 Jan;11(1):169-79.
Motzer RJ, Hutson TE, Hudes GR, Figlin RA, Martini JF, English PA, Huang X, Valota O, Williams JA. Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma. Cancer Chemother Pharmacol. 2014 Oct;74(4):739-50.   PMCID: 4175044
Schilder RJ, Sill MW, Lankes HA, Gold MA, Mannel RS, Modesitt SC, Hanjani P, Bonebrake AJ, Sood AK, Godwin AK, Hu W, Alpaugh RK. A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group study. Gynecol Oncol. 2013 Apr;129(1):86-91.   PMCID: PMC 3712785
Patel RR, Sengupta S, Kim HR, Klein-Szanto AJ, Pyle JR, Zhu F, Li T, Ross EA, Oseni S, Fargnoli J, Jordan VC. Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitors. Eur J Cancer. 2010 Jun;46(9):1537-53.   PMCID: PMC2927957
Plimack ER, Tannir N, Lin E, Bekele BN, Jonasch E. Patterns of disease progression in metastatic renal cell carcinoma patients treated with antivascular agents and interferon: impact of therapy on recurrence patterns and outcome measures. Cancer. 2009 May;115(9):1859-66.
Haas NB, Uzzo RG. Tyrosine kinase inhibitors and anti-angiogenic therapies in kidney cancer. Current treatment options in oncology. 2007 Jun;8(3):211-26.
Meyers MO, Watson JC. Angiogenesis and hepatic colorectal metastases. Surg Oncol Clin N Am. 2003 Jan;12(1):151-63.
Ruggeri BA, Robinson C, Angeles T, Wilkinson Jt, Clapper ML. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth. Clin Cancer Res. 2002 Jan;8(1):267-74.
Ma J, Pulfer S, Li S, Chu J, Reed K, Gallo JM. Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470. Cancer Res. 2001 Jul 15;61(14):5491-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Angiogenesis Inhibitors

Angiogenesis Inhibitors pathology drug therapy therapeutic use metabolism Kidney Neoplasms antagonists & inhibitors Renal Cell Carcinoma blood supply genetics Pathologic Neovascularization Male methods Pyrroles Indoles Vascular Endothelial Growth Factor A Female blood Disease Progression Neoplasm Metastasis Drug Dose-Response Relationship analogs & derivatives adverse effects drug effects Human chemistry pharmacokinetics Vascular Endothelial Growth Factor Receptors Disease-Free Survival Organ Sparing Treatments administration & dosage Mice Nephrons Nude Mice therapy Liver Treatment Outcome US Gov't Support-PHS Animal Sulfonamides Heterologous Transplantation Pyrimidines Cultured Tumor Cells Protein Kinase Inhibitors Antineoplastic Combined Chemotherapy Protocols Protein-Tyrosine Kinases Nephrectomy physiology pharmacology Middle Aged Rats Carcinogenesis Platelet-Derived Growth Factor Experimental Neoplasms Single Nucleotide Polymorphism Drug Monitoring Growth Factor Receptors Triazines analysis Crisp Enzyme Inhibitors Amino Acid Sequence Endothelial cells Dacarbazine Neoplasms Vascular Endothelial Growth Factor Receptor-2 Molecular Sequence Data Outcome Assessment (Health Care) 80 and over Aged Cell Division Angiogenesis Angiogenic Proteins Cell Movement purification isolation & Immunohistochemistry Dialysis Solutions Cell Proliferation Retrospective Studies Antitumor Drug Screening Assays Random Allocation Insulin-Like Growth Factor I Glial Cell Line-Derived Neurotrophic Factor Migration Quail Platelet-Derived Growth Factor beta Receptor alpha Subunit Hypoxia-Inducible Factor 1 Prognosis Colorectal Neoplasms Tamoxifen Breast Neoplasms Niacinamide anti-angiogenesis therapy Xenograft Model Antitumor Assays Carbonic Anhydrases Pancreatic Ribonuclease Antineoplastic Agents Physiologic Neovascularization Microdialysis Ovarian Neoplasms Local Neoplasm Recurrence Neoplasm DNA pericytes Alanine Neoplasm Transplantation immunology Von Hippel-Lindau Tumor Suppressor Protein Receptor Protein-Tyrosine Kinases Pyrazines Fallopian Tube Neoplasms Endothelial Cells Alkylating Antineoplastic Agents Cell proliferation administration & Chorioallantoic Membrane Recurrence Clear Cell Adenocarcinoma Anticarcinogenic Agents Non-US Gov't Support neoplasms Glioma Protein Conformation Viper Venoms Peritoneal Neoplasms enzymology Fibroblast Growth Factor Receptor-Type 1 Human Umbilical Vein Endothelial Cells Fibroblast Growth Factor Receptors Aged Neoplasm Antigens Cell Adhesion Molecules Adult Neoplasm Proteins Interferon-alpha neovascularization Signal Transduction secondary Nude Rats Matrix Metalloproteinases prevention & control isolation & purification angiogenesis-modulating agents dosage Tumor Cell Line Oligonucleotide Array Sequence Analysis Drug Interactions Angiopoietin-2 Tumor Biomarkers Drug Administration Schedule Sesquiterpenes
Last updated on Thursday, April 02, 2020